Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.63 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.63 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.63 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.63 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.63 |
| ▸ | ACACB | O00763 | 1/20 | 0.57 |
| ▸ | HPGD | P15428 | 2/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.51 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.51 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11697049 | 0.90 | TAAR1 (0.60) | TAAR1SLC6A4SLC6A2SLC6A3CYP2D6 | |
| SCHEMBL24218807 | 0.88 | TAAR1 (0.62) | TAAR1SLC6A4SLC6A2SLC6A3CYP2D6 | |
| SCHEMBL15624537 | 0.88 | TAAR1 (0.62) | TAAR1SLC6A4SLC6A2SLC6A3CYP2D6 | |
| SCHEMBL25391470 | 0.86 | TAAR1 (0.67) | TAAR1SLC6A4SLC6A2SLC6A3CYP2D6 | |
| SCHEMBL25201048 | 0.86 | TAAR1 (0.67) | TAAR1SLC6A4SLC6A2SLC6A3CYP2D6 | |
| SCHEMBL11745127 | 0.86 | TAAR1 (0.67) | TAAR1SLC6A4SLC6A2SLC6A3CYP2D6 | |
| SCHEMBL25391472 | 0.86 | TAAR1 (0.67) | TAAR1SLC6A4SLC6A2SLC6A3CYP2D6 | |
| SCHEMBL26238861 | 0.86 | TAAR1 (0.67) | TAAR1SLC6A4SLC6A2SLC6A3CYP2D6 | |
| SCHEMBL26983120 | 0.86 | TAAR1 (0.67) | TAAR1SLC6A4SLC6A2SLC6A3CYP2D6 | |
| SCHEMBL28939114 | 0.85 | TAAR1 (0.62) | TAAR1SLC6A4SLC6A2SLC6A3CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 212 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260060991-A1 | METHODS AND COMPOSITIONS FOR INHIBITING CLONAL HEMATOPOIESIS | THE JACKSON LABORATORY (US) | 2026-03-05 | — | — | US | claimed |
| EP-4376952-A1 | ANTI-SIRP-ALPHA ANTIBODIES AND METHODS OF USE THEREOF | Alector LLC (US) | 2024-06-05 | — | — | EP | claimed |
| CN-112863070-B | Monitoring system and monitoring method of intelligent tool cabinet | 江苏未来智慧信息科技有限公司 | 2024-03-29 | — | — | CN | claimed |
| WO-2024041228-A1 | FEED LIQUID FOR PRODUCTION OF POLYSIALIC ACID, AND PREPARATION METHOD FOR POLYSIALIC ACID | 山东合成远景生物科技有限公司 | 2024-02-29 | — | — | WO | claimed |
| CN-117106152-A | Solvent-free waterproof moisture-permeable double-component polyurethane composition and preparation method and application thereof | 广州贵福爵科技有限公司 | 2023-11-24 | — | — | CN | claimed |
| CN-111733092-B | Method for producing polysialic acid by fermentation and extraction and refining method thereof | 中科鸿基生物科技有限公司 | 2023-10-31 | — | — | CN | claimed |
| WO-2023010076-A1 | ANTI-SIRP-ALPHA ANTIBODIES AND METHODS OF USE THEREOF | ALECTOR LLC (US) | 2023-02-02 | — | — | WO | claimed |
| CN-115125278-B | Feed supplement liquid for producing polysialic acid and preparation method of polysialic acid | 山东合成远景生物科技有限公司 | 2022-11-18 | — | — | CN | claimed |
| CN-115125278-A | Feed supplement liquid for producing polysialic acid and preparation method of polysialic acid | 山东合成远景生物科技有限公司 | 2022-09-30 | — | — | CN | claimed |
| CN-114805159-A | Synthetic process of paricalcitol | 正大制药（青岛）有限公司 | 2022-07-29 | — | — | CN | claimed |
| CN-122012005-A | Bi-component polyurethane adhesive and preparation method and application thereof | 江苏长能节能新材料科技有限公司 | 2026-05-12 | — | — | CN | disclosed |
| US-12624290-B2 | Method for reducing white flicker | MERCK PATENT GMBH (DE) | 2026-05-12 | — | — | US | disclosed |
| EP-4021661-B1 | HOT-CURING MOULD MATERIAL FOR PRODUCING CORES AND MOULDS IN THE SAND CASTING PROCESS | BINDUR GMBH (DE) | 2026-05-06 | — | — | EP | disclosed |
| US-12618007-B2 | Liquid-crystalline medium | MERCK PATENT GMBH (DE) | 2026-05-05 | — | — | US | disclosed |
| US-20260116912-A1 | NEUROACTIVE STEROIDS, COMPOSITIONS, AND USES THEREOF | SAGE THERAPEUTICS INC (US) | 2026-04-30 | — | — | US | disclosed |
| US-20220112426-A1 | LIQUID-CRYSTAL MEDIUM | MERCK PATENT GMBH (DE) | 2022-04-14 | — | — | US | disclosed |
| US-20220110950-A1 | 19-NOR C3, 3-DISUBSTITUTED C21-N-PYRAZOLYL STEROIDS AND METHODS OF USE THEREOF | SAGE THERAPEUTICS, INC. | 2022-04-14 | — | — | US | disclosed |
| US-11261211-B2 | 19-NOR neuroactive steroids and methods of use thereof | SAGE THERAPEUTICS, INC. (US) | 2022-03-01 | — | — | US | disclosed |
| CN-114106280-A | Aliphatic polyurethane resin and preparation method and application thereof | 上海华峰新材料研发科技有限公司 | 2022-03-01 | — | — | CN | disclosed |
| US-11254872-B2 | Liquid crystal media comprising polymerisable compounds | MERCK PATENT GMBH (DE) | 2022-02-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260060991-A1 | METHODS AND COMPOSITIONS FOR INHIBITING CLONAL HEMATOPOIESIS | MCL1, TSG101, DNMT3A | TAAR1 4670/4885SLC6A4 4862/4885SLC6A2 4640/4885 |
| US-12618007-B2 | Liquid-crystalline medium | SOST, NES, VIM | TAAR1 2081/4885SLC6A4 511/4885SLC6A2 214/4885 |
| US-20220110950-A1 | 19-NOR C3, 3-DISUBSTITUTED C21-N-PYRAZOLYL STEROIDS AND METHODS OF USE THEREOF | NR3C2, NR3C1, CYP11B1 | TAAR1 140/4885SLC6A4 226/4885SLC6A2 585/4885 |
| US-20260116912-A1 | NEUROACTIVE STEROIDS, COMPOSITIONS, AND USES THEREOF | SCN4A, CHRNA4, CACNG4 | TAAR1 269/4885SLC6A4 4/4885SLC6A2 39/4885 |
| US-12624290-B2 | Method for reducing white flicker | HCN4, HCN2, HCN3 | TAAR1 2177/4885SLC6A4 2078/4885SLC6A2 1307/4885 |
| US-11261211-B2 | 19-NOR neuroactive steroids and methods of use thereof | NR3C2, HSD3B1, NR3C1 | TAAR1 127/4885SLC6A4 135/4885SLC6A2 192/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.